Ms. Lisa Carson's most recent trade in Phio Pharmaceuticals Corp was a trade of 108,000 shares done . Disclosure was reported to the exchange on Sept. 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phio Pharma Corp | Ms. Lisa Carson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2026 | 108,000 | 189,112 (10%) | 5% | 0 | - | |
| Phio Pharma Corp | Ms. Lisa Carson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.03 per share. | 11 Sep 2026 | 12,888 | 81,112 (4%) | 0% | 1.0 | 13,275 | Common Stock, $.0001 par value |
| Phio Pharma Corp | Ms. Lisa Carson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 47,000 | 94,000 (5%) | 2% | 0 | Common Stock, $.0001 par value | |
| Phio Pharma Corp | Ms. Lisa Carson | VP, Finance and Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 47,000 | 47,000 (2%) | 2% | 0 | Common Stock, $.0001 par value |